Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.

Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedA notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.7%

- Check23 days agoChange DetectedThe site footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check30 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record history shows a capitalization tweak of the contact information label and a new revision tag (v3.7.0) replacing the previous v3.6.6, reflecting a small metadata/UI update rather than substantive content changes.SummaryDifference0.2%

- Check72 days agoChange DetectedNew revision v3.6.6 appears in the Study Record History, replacing the prior v3.6.5. This update reflects an internal metadata change to the record rather than a modification of core study content.SummaryDifference0.1%

Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.